To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 15 shares, the number of shares held increased 0.13% compared to the previous period and now represents 1.06% of the total position.
      30Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 13,310 shares, the number of shares held increased 0.13% compared to the previous period and now represents 1.43% of the total position.
      1.72KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in BioNTech SE by 153 shares, the number of shares held increased 0.13% compared to the previous period and now represents 1.04% of the total position.
      48Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 15,174 shares, the number of shares held increased 0.13% compared to the previous period and now represents 3.77% of the total position.
      5.93K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Natera by 294 shares, the number of shares held increased 0.13% compared to the previous period and now represents 4.56% of the total position.
      64Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 6,353 shares, the number of shares held increased 1.76% compared to the previous period and now represents 2.25% of the total position.
      25Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 3,741 shares, the number of shares held decreased 0.39% compared to the previous period and now represents 2.9% of the total position.
      64Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 348 shares, the number of shares held increased 0.13% compared to the previous period and now represents 1.92% of the total position.
      98Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 6,350 shares, the number of shares held increased 0.13% compared to the previous period and now represents 1.93% of the total position.
      127Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 2,685 shares, the number of shares held increased 0.13% compared to the previous period and now represents 5.01% of the total position.
      198Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed